3rd Nov 2005 18:11
GlaxoSmithKline PLC03 November 2005 Director's Interests I give below details of changes in interests in the Ordinary shares ofGlaxoSmithKline plc in respect of the under-mentioned Person DischargingManagerial Responsibility:- Mr R Bondy Exercise of nil-price options on 1 November 2005 over 2,094 Ordinary shares granted on 15 February 2002 under the SmithKline Beecham Mid-Term Incentive Plan ("the MTIP"), resulting from the deferral of an award made under the MTIP on 23 November 1998. Exercise of nil-price options on 1 November 2005 over 2,094 Ordinary shares granted on 13 February 2003 under the MTIP, resulting from the deferral of an award made under the MTIP on 24 November 1999. Sale of 1,718 Ordinary shares at a price of £14.6636 per share. The Company was advised of these transactions on 3 November 2005. This notification relates to a transaction notified in accordance withDisclosure Rule 3.1.4R(1)(a). S M BicknellCompany Secretary 3 November 2005 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline